Forget Spacex's Nasdaq-100 Inclusion: A Bigger Catalyst Ahead
As July nears, chatter over SpaceX joining the Nasdaq-100 swirls. This article argues that a bigger, more reliable ca...
This guide weighs the advantages and drawbacks of target date versus lifecycle funds to help you pick the option that best fits your retirement plan.
25,428 articlesAs July nears, chatter over SpaceX joining the Nasdaq-100 swirls. This article argues that a bigger, more reliable ca...
A significant stake in Clearwater Analytics has sparked renewed interest in the company’s SaaS-driven investment acco...
A wave of weaker confidence is reshaping housing activity, even as the job market holds steady. This guide breaks dow...
NVIDIA just slipped below a historic milestone, reigniting the debate about who could realistically challenge its AI ...
NuScale Power has sparked excitement around small modular reactors, but does the hype translate into real investing u...
A major stake sale in Arcellx coincides with fresh competition in the field. This analysis breaks down what happened,...
A breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
The next five years could redefine SpaceX’s place in markets from launches to internet services. This guide breaks do...
Space infrastructure hurdles are shrinking as Redwire reports stronger backlog and new contracts. This week, redwire ...
High-fashion moments at the Met Gala often collide with financial realities. This article uses one eye-catching eveni...
A notable institutional purchase in Plains GP Holdings hints at a larger, value-driven view of the energy midstream s...
Anchorage draws retirees with rugged scenery, yet living costs and healthcare pose stiff tests for portfolios. A prac...